Publication | Closed Access

Del-1 enhances therapeutic efficacy of bacterial cancer immunotherapy by blocking recruitment of tumor-infiltrating neutrophils

Tumor ImmunologyCancer ImmunosurveillanceTumor-infiltrating NeutrophilsMedicineImmunologyImmunoeditingImmune Checkpoint InhibitorImmunomodulationBacterial Cancer ImmunotherapyImmunotherapyOncologyRadiation OncologyTumor Microenvironment